Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000928464-12-000198
Filing Date
2012-08-09
Accepted
2012-08-09 10:54:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 frxsch13damd14080912.htm SC 13D/A 26085
2 STATEMENT frxsch13damd14080912ex1.htm EX-1 13740
3 IEH/ENDE AMENDMENT frxsch13damd14080912ex2.htm EX-2 13125
4 HR/ENDE AMENDMENT frxsch13damd14080912ex3.htm EX-3 12964
  Complete submission text file 0000928464-12-000198.txt   67578
Mailing Address 909 THIRD AVENUE NEW YORK NY 10022
Business Address 909 THIRD AVENUE NEW YORK NY 10022 (212)421-7850
FOREST LABORATORIES INC (Subject) CIK: 0000038074 (see all company filings)

EIN.: 111798614 | State of Incorp.: DE | Fiscal Year End: 1202
Type: SC 13D/A | Act: 34 | File No.: 005-30414 | Film No.: 121019034
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153 212-702-4300
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 0000